Nemaura Medical Inc.
Company Snapshot: Nemaura Medical Inc.
NMRD | ||||
Last | Change | Volume | High | Low |
Company Overview

Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes specialty medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as for screening pre-diabetic patients. The company was founded in 2009 and is headquartered in Loughborough, the United Kingdom.
Client News
- Mar 2 2021 Nemaura Medical to Present at the H.C. Wainwright Global Life Sciences Conference
- Feb 16 2021 Nemaura Medical Reports Financial Results for Third Quarter of Fiscal Year 2021 and Provides Corporate Update
- Feb 11 2021 Nemaura Medical Secures $20 Million Non-Dilutive Loan to Accelerate Business Growth
- Feb 4 2021 Nemaura Medical Appoints Thomas Mortensen as Head of E.U. Commercial Operations and Marketing